Sodium Nitroprusside Injection, Solution
Product Images NDC 14335-134

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 14335-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 mL_0.2 Carton (Image 01)

50 mL_0.2 Carton (Image 01)
Packaging label for Sodium Nitroprusside 10 mg/50 mL (0.2 mg/mL) Injection, Sodium Chloride Injection, ready to use, single-dose vial for intravenous infusion. It includes storage instructions to protect from light and keep at 20°C to 25°C. Labeler is Hainan Poly Pharm. Co., Ltd., with branding 'POLY PHARM'.*
FDA Label Image

50 mL_0.2 Vial Label (Image 02)

50 mL_0.2 Vial Label (Image 02)
Label for Sodium Nitroprusside injection solution 10 mg/50 mL (0.2 mg/mL) in 0.9% Sodium Chloride, intravenous use, single dose vial. Manufactured by Hainan Poly Pharm. Co., Ltd. The label includes storage instructions and a barcode.*
FDA Label Image

0.5 mg Vial (Image 03)

0.5 mg Vial (Image 03)
Sodium Nitroprusside 0.5 mg/mL injection solution in 0.9% Sodium Chloride, ready to use. This label indicates a 100 mL single dose vial for intravenous infusion only, manufactured by Hainan Poly Pharm. Co., Ltd. Storage instructions and bar code are also visible on the label.*
FDA Label Image

100 mL_0.2 mg Vial (Image 04)

100 mL_0.2 mg Vial (Image 04)
Label for Sodium Nitroprusside injection, solution in 0.9% sodium chloride, 20 mg/100 mL (0.2 mg/mL) strength. This is a 100 mL single-dose vial for intravenous infusion only. Manufactured by Hainan Poly Pharm. Co., Ltd. Storage instructions and barcode are also provided on the label.*
FDA Label Image

0.5 Carton (Image 05)

0.5 Carton (Image 05)
Packaging label for Sodium Nitroprusside injection, solution in 0.9% Sodium Chloride, 50 mg/100 mL (0.5 mg/mL) strength, for intravenous infusion. The label indicates a 100 mL single-dose vial, with instructions to discard unused portions and protect from light by storing in the carton until use. Manufactured by Hainan Poly Pharm. Co., Ltd.*
FDA Label Image

100 mL_0.2 mg Carton (Image 06)

100 mL_0.2 mg Carton (Image 06)
Sodium Nitroprusside 0.2 mg/mL injection, solution in 0.9% sodium chloride, in a 100 mL single dose vial. Label indicates ready-to-use intravenous infusion, containing 20 mg of sodium nitroprusside per 100 mL solution. Manufacturer is Hainan Poly Pharm. Co., Ltd. Packaging includes storage instructions to protect from light and store at controlled room temperature.*
FDA Label Image

Structure (Spl Image1 Structure)

Structure (Spl Image1 Structure)
Chemical structure of sodium nitroprusside, showing an iron (Fe) center coordinated with five cyanide (CN) groups and one nitrosyl (NO) group, along with two sodium ions (Na+) and two water molecules (H2O) indicated.*
FDA Label Image

Image Descriptionmetabolic Pathway (Spl Image2 Metabolism Flow)

Image Descriptionmetabolic Pathway (Spl Image2 Metabolism Flow)
A schematic diagram titled 'Metabolism of Sodium Nitroprusside' illustrating the metabolic pathways involving sodium nitroprusside interacting with hemoglobin (Hgb) to form cyanide, cyanmethemoglobin (cyanmetHgb), and methemoglobin (metHgb). The diagram includes conversion to thiocyanate via rhodanase, the role of active and inactive cytochromes, and excretion pathways labeled 'renal out' for thiocyanate, thiocyanate, and other intermediates.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.